Iziguli Zomdlavuza Webele Ezisakhula Manje Zingakwazi Ukugwema Ukwelapha Ngamakhemikhali

A BAMBA MahhalaRelease 1 | eTurboNews | eTN

Ocwaningweni, abesifazane abangemva kokuya esikhathini abanama-node angu-1 kuya ku-3 kanye nemiphumela ye-Recurrence Score® engu-0 kuya ku-25 ayizange ibonise inzuzo ku-chemotherapy ngemva kweminyaka emihlanu yokulandelela, okusho ukuthi bangakwazi ukugwema imiphumela emibi yokwelashwa.

I-Exact Sciences Corp. namuhla imemezele ukuthi idatha evela ku-Rx ye-Positive Node, i-Endocrine Responsive Breast Cancer, noma i-RxPONDER, ukuhlolwa kwanyatheliswa ku-New England Journal of Medicine.i Ucwaningo, oluholwa yi-SWOG Cancer Research Network ezimele futhi luxhaswe yi- I-National Cancer Institute (NCI), ichaze ngempumelelo inzuzo yokwelashwa ngamakhemikhali ekuqaleni kwesigaba, iziguli ezinomdlavuza webele ezine-Oncotype DX Breast Recurrence Score® imiphumela engu-0 kuye ku-25. Imiphumela yokuqala evela ku-RxPONDER yabikwa ku-2020 San Antonio Breast Cancer. I-Symposium (SABCS). Okutholakele manje sekuqinisekisiwe kulokhu kushicilelwa okubuyekezwe ngontanga.

Okubalulekile, akukho nzuzo ye-chemotherapy eyabonwa kungakhathaliseki ukuthi ingakanani indawo ethintekile, ibanga lesimila noma usayizi. Kwabesifazane abangaphambi kokuya esikhathini abanama-node angu-1 kuya kwangu-3, ​​inzuzo enkulu ye-chemotherapy ngokwezibalo yabonwa.

Cishe ingxenye eyodwa kwezintathu yeziguli ezitholwe zine-hormone receptor (HR)-positive, i-HER2-negative umdlavuza webele wangaphambi kwesikhathi zinethumba elisabalele kuma-lymph nodes. Iningi lalezi ziguli njengamanje zithola i-chemotherapyii nakuba cishe ama-85% azo anemiphumela ye-Recurrence Score ka-0 kuya ku-25.iii Ngaphezu kwalokho, cishe iziguli ezimbili kwezintathu zeziguli ezinomdlavuza webele ezitholakala emazingeni aphansi zi-postmenopausal.iv

Ngokusekelwe emiphumeleni ye-RxPONDER, i-National Comprehensive Cancer Network® (NCCN®)v ibuyekeze imihlahlandlela yayo yomdlavuza webele futhi yaqaphela ukuhlolwa kwe-Oncotype DX Breast Recurrence Score njengokuphela kokuhlolwa okungasetshenziswa ukubikezela inzuzo yokwelashwa ngamakhemikhali ekuqaleni kwebele. iziguli ezinomdlavuza ezinama-axillary lymph nodes angu-1 kuya ku-3, okuhlanganisa nama-micrometastases.vi Ukuhlolwa kwe-Oncotype DX manje kuwukuphela kokuhlolwa okubizwa ngokuthi "okuthandwayo" okunobufakazi obuphakeme kakhulu bobufakazi be-node-negative kanye ne-postmenopausal node-positive (1 kuya ku-3 amanodi amahle ) iziguli. Ngaphezu kwalokho, i-NCCN incoma ukucutshungulwa kokuhlolwa ukuze kuhlolwe ukubikezelwa kweziguli ezine-node-positive premenopausal ezidinga ukwelashwa ngamakhemikhali.

Esinye sezivivinyo ezinkulu kakhulu zomtholampilo kumdlavuza webele we-node-positive, i-HR-positive, i-HER2-negative ekuqaleni, i-RxPONDER ibhalise abesifazane abangaphezu kuka-5,000 abanama-node amathathu. Ucwaningo lweSigaba III obekulindelekile, olungahleliwe lwenziwa ezindaweni ezingama-632 emazweni ayisishiyagalolunye - e-United States, Canada, Mexico, Colombia, Ireland, France, Spain, South Korea naseSaudi Arabia. Abesifazane abanomphumela we-Recurrence Score ongu-0 kuye ku-25 bahlelwa ngokungahleliwe ekwelapheni nge-hormone therapy kuphela noma i-chemotherapy elandelwa ukwelapha ngamahomoni. Iziguli ezingahleliwe zahlukaniswa ngokusekelwe kumphumela wazo we-Recurrence Score, isimo sokunqamuka kokuya esikhathini kanye nohlobo lokuhlinzwa kwama-lymph node. Ukuhlaziya okwengeziwe nokulandelela isiguli okwengeziwe kuhlelwa abaphenyi be-SWOG.

Mayelana umbhali

I-avatar ka-Linda Hohnholz, umhleli we-eTN

ULinda Hohnholz, umhleli we-eTN

ULinda Hohnholz ubelokhu ebhala futhi ehlela izindatshana selokhu aqala ukusebenza. Usebenzise le nkanuko yokuzalwa ezindaweni ezifana neHawaii Pacific University, iChaminade University, iHawaii Children's Discovery Center, kanye neTravelNewsGroup manje.

Bhalisa
Yazisa ngakho
isivakashi
0 Amazwana
Okungaphakathi Okuphakelayo
Buka wonke amazwana
0
Ungathanda imibono yakho, ngicela uphawule.x
Yabelana ku...